Lipocine Revenue and Competitors

Location

$66.7M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Lipocine's estimated annual revenue is currently $3.5M per year.(i)
  • Lipocine's estimated revenue per employee is $145,833
  • Lipocine's total funding is $66.7M.

Employee Data

  • Lipocine has 24 Employees.(i)
  • Lipocine grew their employee count by 0% last year.

Lipocine's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$132M368N/AN/AN/A
Add Company

What Is Lipocine?

Lipocine is a specialty pharmaceutical company focused on developing innovative oral treatment alternatives for use in men’s and women’s health using its proprietary drug delivery technologies. Lipocine product development pipeline entails repositioning of established drugs with significantly improved patient compliance through an efficient 505(b) (2) regulatory pathway strategy.

keywords:Biotechnology

$66.7M

Total Funding

24

Number of Employees

$3.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lipocine News

2022-04-17 - Head-To-Head Survey: Argos Therapeutics (OTCMKTS ...

Comparatively, Lipocine has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Analyst Ratings. This is a...

2022-04-06 - LIPOCINE ANNOUNCES BOARD of DIRECTOR ...

SALT LAKE CITY, April 11, 2022 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on neuroendocrine and...

2022-03-22 - Lipocine Shares Drop 14% After Partner Gets FDA Approval for Tlando

Lipocine Inc. shares were down 14% to $1.56 after the company said that Antares Pharma Inc. said the U.S. Food and Drug Administration has...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M240%N/A
#2
$3.7M249%N/A
#3
$6M240%N/A
#4
$4.9M244%N/A
#5
$1.7M2450%N/A